348 related articles for article (PubMed ID: 26980472)
1. Variations in Receipt of Curative-Intent Surgery for Early-Stage Non-Small Cell Lung Cancer (NSCLC) by State.
Sineshaw HM; Wu XC; Flanders WD; Osarogiagbon RU; Jemal A
J Thorac Oncol; 2016 Jun; 11(6):880-9. PubMed ID: 26980472
[TBL] [Abstract][Full Text] [Related]
2. County-Level Variations in Receipt of Surgery for Early-Stage Non-small Cell Lung Cancer in the United States.
Sineshaw HM; Sahar L; Osarogiagbon RU; Flanders WD; Yabroff KR; Jemal A
Chest; 2020 Jan; 157(1):212-222. PubMed ID: 31813533
[TBL] [Abstract][Full Text] [Related]
3. Safety-net burden hospitals and likelihood of curative-intent surgery for non-small cell lung cancer.
Virgo KS; Little AG; Fedewa SA; Chen AY; Flanders WD; Ward EM
J Am Coll Surg; 2011 Nov; 213(5):633-43. PubMed ID: 21907598
[TBL] [Abstract][Full Text] [Related]
4. Trends and Disparities in Curative-Intent Treatment for Early-Stage Non-Small Cell Lung Cancer: A Population-Based Analysis of Surgery and SBRT.
Liu Q; Medina HN; Rodriguez E; Jacobs KT; Brown C; Koru-Sengul T; Lopes G; Pinheiro PS
Cancer Epidemiol Biomarkers Prev; 2024 Apr; 33(4):489-499. PubMed ID: 38252069
[TBL] [Abstract][Full Text] [Related]
5. Influence of comorbidity on racial differences in receipt of surgery among US veterans with early-stage non-small-cell lung cancer.
Williams CD; Stechuchak KM; Zullig LL; Provenzale D; Kelley MJ
J Clin Oncol; 2013 Feb; 31(4):475-81. PubMed ID: 23269988
[TBL] [Abstract][Full Text] [Related]
6. The effect of race on invasive staging and surgery in non-small-cell lung cancer.
Lathan CS; Neville BA; Earle CC
J Clin Oncol; 2006 Jan; 24(3):413-8. PubMed ID: 16365180
[TBL] [Abstract][Full Text] [Related]
7. Characteristics associated with the use of nonanatomic resections among Medicare patients undergoing resections of early-stage lung cancer.
Kim AW; Detterbeck FC; Boffa DJ; Decker RH; Soulos PR; Cramer LD; Gross CP
Ann Thorac Surg; 2012 Sep; 94(3):895-901. PubMed ID: 22835558
[TBL] [Abstract][Full Text] [Related]
8. Surgical Disparities Among Patients With Stage I Lung Cancer in the National Lung Screening Trial.
Balekian AA; Wisnivesky JP; Gould MK
Chest; 2019 Jan; 155(1):44-52. PubMed ID: 30056040
[TBL] [Abstract][Full Text] [Related]
9. Treatment disparities for disabled medicare beneficiaries with stage I non-small cell lung cancer.
Iezzoni LI; Ngo LH; Li D; Roetzheim RG; Drews RE; McCarthy EP
Arch Phys Med Rehabil; 2008 Apr; 89(4):595-601. PubMed ID: 18373987
[TBL] [Abstract][Full Text] [Related]
10. Urban/rural patterns in receipt of treatment for non-small cell lung cancer among black and white Medicare beneficiaries, 2000-2003.
Steele CB; Pisu M; Richardson LC
J Natl Med Assoc; 2011 Aug; 103(8):711-8. PubMed ID: 22046848
[TBL] [Abstract][Full Text] [Related]
11. Outcomes of a Highly Selective Surgical Approach to Oligometastatic Lung Cancer.
Johnson KK; Rosen JE; Salazar MC; Boffa DJ
Ann Thorac Surg; 2016 Oct; 102(4):1166-71. PubMed ID: 27344278
[TBL] [Abstract][Full Text] [Related]
12. Racial Differences in Treatment and Survival among Veterans and Non-Veterans with Stage I NSCLC: An Evaluation of Veterans Affairs and SEER-Medicare Populations.
Williams CD; Alpert N; Redding TS; Bullard AJ; Flores RM; Kelley MJ; Taioli E
Cancer Epidemiol Biomarkers Prev; 2020 Jan; 29(1):112-118. PubMed ID: 31624076
[TBL] [Abstract][Full Text] [Related]
13. Pulmonologist involvement, stage-specific treatment, and survival in adults with non-small cell lung cancer and chronic obstructive pulmonary disease.
Deepak JA; Ng X; Feliciano J; Mao L; Davidoff AJ
Ann Am Thorac Soc; 2015 May; 12(5):742-51. PubMed ID: 25760983
[TBL] [Abstract][Full Text] [Related]
14. Racial disparities and treatment trends in a large cohort of elderly black and white patients with nonsmall cell lung cancer.
Hardy D; Liu CC; Xia R; Cormier JN; Chan W; White A; Burau K; Du XL
Cancer; 2009 May; 115(10):2199-211. PubMed ID: 19365824
[TBL] [Abstract][Full Text] [Related]
15. Race/Ethnicity-specific Disparities in Hepatocellular Carcinoma Stage at Diagnosis and its Impact on Receipt of Curative Therapies.
Ha J; Yan M; Aguilar M; Tana M; Liu B; Frenette CT; Bhuket T; Wong RJ
J Clin Gastroenterol; 2016; 50(5):423-30. PubMed ID: 26583267
[TBL] [Abstract][Full Text] [Related]
16. The impact of curative intent surgery on the survival of pancreatic cancer patients: a U.S. Population-based study.
Shaib Y; Davila J; Naumann C; El-Serag H
Am J Gastroenterol; 2007 Jul; 102(7):1377-82. PubMed ID: 17403071
[TBL] [Abstract][Full Text] [Related]
17. Population-based analysis of curative therapies in stage II non-small cell lung cancer: the role of radiotherapy in medically inoperable patients.
Moore S; Leung B; Wu J; Ho C
Radiat Oncol; 2020 Jan; 15(1):23. PubMed ID: 32000829
[TBL] [Abstract][Full Text] [Related]
18. Underuse of surgical resection for localized, non-small cell lung cancer among whites and African Americans in South Carolina.
Esnaola NF; Gebregziabher M; Knott K; Finney C; Silvestri GA; Reed CE; Ford ME
Ann Thorac Surg; 2008 Jul; 86(1):220-6; discussion 227. PubMed ID: 18573427
[TBL] [Abstract][Full Text] [Related]
19. Disparities in lung cancer survival and receipt of surgical treatment.
Osuoha CA; Callahan KE; Ponce CP; Pinheiro PS
Lung Cancer; 2018 Aug; 122():54-59. PubMed ID: 30032845
[TBL] [Abstract][Full Text] [Related]
20. Race and health disparities in patient refusal of surgery for early-stage non-small cell lung cancer: a SEER cohort study.
Mehta RS; Lenzner D; Argiris A
Ann Surg Oncol; 2012 Mar; 19(3):722-7. PubMed ID: 21947698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
